SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
scientific article published on 05 August 2020
Author/s
author: Kenneth H Dinnon Iii, Kevin W Bock, Emily Phung, Lauren A Chang, Mark K. Louder, Eun Sung Yang, Daniel Wrapp, Martha Nason, Tracy J Ruckwardt, Jason S. McLellan, Mark R. Denison, Andrea Carfì, Barney S. Graham, Ralph S. Baric, Kizzmekia Corbett, James David Chappell, Olubukola Abiona, Nianshuang Wang, John R. Mascola, Guillaume Stewart-Jones, Kaitlyn M Morabito, Seyhan Boyoğlu-Barnum, Nicole Doria-Rose, Elisabeth Humphris-Narayanan, Lingshu Wang, Bianca M Nagata, Rebecca A Gillespie, Rebecca J. Loomis, Sayda M Elbashir, Sarah R Leist, Kendra Gully, Gabriela Alvarado, Alexandra Schäfer, Wing-Pui Kong, Laura J. Stevens, Anthony T DiPiazza, David R Martinez, Stephen D Schmidt, Darin K Edwards, Cynthia T Ziwawo, Christine A Shaw, Ethan J Fritch, Mahnaz Minai, Dario Garcia-Dominguez, Nedim Emil Altaras, Mihir Metkar, Vlad Presnyak, Kwanyee Leung, Ande West, Carole Henry
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.